Skip to content

Improving Lung Transplant Outcomes With Coping Skills and Physical Activity

Improving Lung Transplant Outcomes With Coping Skills and Physical Activity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04093869
Acronym
INSPIRE-III
Enrollment
180
Registered
2019-09-18
Start date
2019-11-06
Completion date
2026-02-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Lung Transplantation

Brief summary

This study evaluates the effectiveness of a coping skills and exercise (CSTEX) intervention among post lung transplant patients aimed to reduce distress and improve functional capacity. Half of the patients will receive CSTEX and half will receive the standard of care plus transplant education (SOC-ED).

Detailed description

The study will aim to evaluate the effectiveness of the CSTEX intervention in (i) reducing distress and (ii) improving functional capacity. It is hypothesized that compared to SOC-ED, the CSTEX intervention will result in 1) greater reductions in global distress measured by an established psychometric test battery; and 2) greater improvements in functional capacity assessed by distance walked on a standard Six Minute Walk test (6MWT).

Interventions

BEHAVIORALCoping Skills Training combined with Exercise (CSTEX)

The CSTEX condition has two integrated components: the CST component will systematically train patients in the use of coping skills for stress reduction and promote key transplant-specific health behaviors. The exercise component of the intervention will progressively increase participants exercise and promote daily physical activity through motivational interviewing strategies.

BEHAVIORALStandard of Care plus Education (SOC-ED)

The SOC-ED condition provides support and enhanced post-transplant education. Participants will be given detailed educational information about post-transplant care, the importance of medication adherence, and maintenance of physical activity.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Single or bilateral first lung transplant recipient; discharged from the hospital and at least 6 weeks post-transplant; completed post-transplant pulmonary rehabilitation within the past 18 months; on stable medication regimen; proficient in the English language

Exclusion criteria

* Illness such as malignancies that are associated with a life-expectancy of \< 12 months; current pregnancy; inability to read or to provide informed consent; multi-organ transplant recipient or repeat lung transplant.

Design outcomes

Primary

MeasureTime frameDescription
Change in Global Psychological DistressBaseline to 12 weeksA composite distress score will assess change from baseline to 12 weeks (post-intervention) and combine the following instruments: General Health Questionnaire, Perceived Stress Scale, Beck Depression Inventory-II, State Trait Anxiety Inventory, and PROMIS Anger. The composite distress score is the average of the participant's rank for change (from baseline to 12 weeks) on each of the 5 scales. A lower rank represents more improvement (decrease in global distress) and higher ranks represent less improvement (or worsening of distress). Scoring is based on the number of participants analyzed; in this case the possible score range is 1-180. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Secondary

MeasureTime frameDescription
Change in Functional CapacityBaseline to 12 weeksFunctional capacity will be measured by distance walked on a standard Six Minute Walk Test (6MWT) at baseline and again post-intervention at 12 weeks. Distance measured in feet. Greater distance represents better functional capacity. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Physical ActivityBaseline to 12 weeksDaily physical activity (average steps per day) will be assessed via a wrist-worn activity monitor (Actigraph GT9X Link) for 7 consecutive days at baseline and again post-intervention at 12 weeks. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Sleep QualityBaseline to 12 weeksSleep quality (average total minutes of sleep per night) will be assessed via the Pittsburgh Sleep Quality Index at baseline and again post-intervention at 12 weeks. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Quality of LifeBaseline to 12 weeksQuality of Life will be assessed via the Lung Transplant Quality of Life Survey, which is comprised of 10 scales that measure symptoms, health perceptions, functioning, and well being at baseline and again post-intervention at 12 weeks. The QOL overall score ranges from 1 to 5, with a higher score indicating worse health. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in FrailtyBaseline to 12 weeksFrailty will be measured by performance on the Fried Frailty Index. This assessment includes measures on patient's weight, exhaustion level, physical activity, walking speed, and hand grip strength at baseline and again post-intervention at 12 weeks. Scores range from 0 to 5, with lower scores indicating less frailty. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Problem-Focused CopingBaseline to 12 weeksCoping was assessed via the Brief COPE Inventory, which is composed of scales that measure problem-focused coping, emotion-focused coping, and avoidant coping responses at baseline and again post-intervention at 12 weeks. Items are scored on a 4-point Likert scale, with 1 indicating a coping mechanism that the participant has not been doing at all, to 4 indicating a coping mechanism in which the participant has been doing a lot. A higher average score within the problem-focused subscale indicates better coping strategies. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Emotion-Focused CopingBaseline to 12 weeksCoping was assessed via the Brief COPE Inventory, which is composed of scales that measure problem-focused coping, emotion-focused coping, and avoidant coping responses at baseline and again post-intervention at 12 weeks. Items are scored on a 4-point Likert scale, with 1 indicating a coping mechanism that the participant has not been doing at all, to 4 indicating a coping mechanism in which the participant has been doing a lot. A higher score within the emotion-focused coping subscale indicates better coping strategies. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Avoidant CopingBaseline to 12 weeksCoping was assessed via the Brief COPE Inventory, which is composed of scales that measure problem-focused coping, emotion-focused coping, and avoidant coping responses at baseline and again post-intervention at 12 weeks. Items are scored on a 4-point Likert scale, with 1 indicating a coping mechanism that the participant has not been doing at all, to 4 indicating a coping mechanism in which the participant has been doing a lot. A lower score within the avoidant coping subscale indicates a more useful coping strategy. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Change in Self-EfficacyBaseline to 12 weeksSelf-efficacy will be assessed via the General Self-Efficacy Scale, which is a 10-item scale that measures emotional distress at baseline and again post-intervention at 12 weeks. Scores range from 10-40 with a higher score indicating better self-efficacy. The change value is calculated as T2 (12 weeks) - T1 (baseline).
Chronic Lung Allograft Dysfunction (CLAD) Free SurvivalUp to 3 years post-treatment

Countries

United States

Participant flow

Pre-assignment details

Participants were randomly assigned in a 1:1 ratio to either CSTEX condition delivered over the telephone or to a standard of care plus transplant education (SoC-ED) control condition.

Participants by arm

ArmCount
Coping Skills Training Combined With Exercise (CSTEX)
The CSTEX intervention will consist of 12, 30 minute weekly sessions conducted by a respiratory therapist knowledgeable about lung transplantation and trained in motivational interviewing, Cognitive Behavioral Therapy (CBT), and exercise therapy. Coping Skills Training combined with Exercise (CSTEX): The CSTEX condition has two integrated components: the CST component will systematically train patients in the use of coping skills for stress reduction and promote key transplant-specific health behaviors. The exercise component of the intervention will progressively increase participants exercise and promote daily physical activity through motivational interviewing strategies.
90
Standard of Care Plus Education (SOC-ED)
The SOC-ED intervention will consist of 12, 30 minute weekly sessions conducted by a health educator knowledgeable about transplantation and skilled in educational instruction. Standard of Care plus Education (SOC-ED): The SOC-ED condition provides support and enhanced post-transplant education. Participants will be given detailed educational information about post-transplant care, the importance of medication adherence, and maintenance of physical activity.
90
Total180

Baseline characteristics

CharacteristicStandard of Care Plus Education (SOC-ED)TotalCoping Skills Training Combined With Exercise (CSTEX)
Age, Continuous60 years
STANDARD_DEVIATION 12
60 years
STANDARD_DEVIATION 12
60 years
STANDARD_DEVIATION 12
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants3 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
88 Participants177 Participants89 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Black or African American
14 Participants25 Participants11 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
74 Participants151 Participants77 Participants
Region of Enrollment
United States
90 Participants180 Participants90 Participants
Sex: Female, Male
Female
37 Participants72 Participants35 Participants
Sex: Female, Male
Male
53 Participants108 Participants55 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 901 / 90
other
Total, other adverse events
0 / 900 / 90
serious
Total, serious adverse events
0 / 900 / 90

Outcome results

Primary

Change in Global Psychological Distress

A composite distress score will assess change from baseline to 12 weeks (post-intervention) and combine the following instruments: General Health Questionnaire, Perceived Stress Scale, Beck Depression Inventory-II, State Trait Anxiety Inventory, and PROMIS Anger. The composite distress score is the average of the participant's rank for change (from baseline to 12 weeks) on each of the 5 scales. A lower rank represents more improvement (decrease in global distress) and higher ranks represent less improvement (or worsening of distress). Scoring is based on the number of participants analyzed; in this case the possible score range is 1-180. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: 3 participants were excluded because they had missing values for at least one of the instruments that contributed to the composite distress score.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Global Psychological Distress91 units on a scaleStandard Deviation 40
Standard of Care Plus Education (SOC-ED)Change in Global Psychological Distress87 units on a scaleStandard Deviation 33
p-value: 0.495% CI: [-6, 14]Regression, Linear
Secondary

Change in Avoidant Coping

Coping was assessed via the Brief COPE Inventory, which is composed of scales that measure problem-focused coping, emotion-focused coping, and avoidant coping responses at baseline and again post-intervention at 12 weeks. Items are scored on a 4-point Likert scale, with 1 indicating a coping mechanism that the participant has not been doing at all, to 4 indicating a coping mechanism in which the participant has been doing a lot. A lower score within the avoidant coping subscale indicates a more useful coping strategy. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: Two participants were missing a Brief COPE score at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Avoidant Coping1.45 score on a scaleStandard Deviation 0.36
Standard of Care Plus Education (SOC-ED)Change in Avoidant Coping1.46 score on a scaleStandard Deviation 0.34
95% CI: [-0.12, 0.07]
Secondary

Change in Emotion-Focused Coping

Coping was assessed via the Brief COPE Inventory, which is composed of scales that measure problem-focused coping, emotion-focused coping, and avoidant coping responses at baseline and again post-intervention at 12 weeks. Items are scored on a 4-point Likert scale, with 1 indicating a coping mechanism that the participant has not been doing at all, to 4 indicating a coping mechanism in which the participant has been doing a lot. A higher score within the emotion-focused coping subscale indicates better coping strategies. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: Two participants were missing a Brief COPE score at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Emotion-Focused Coping2.26 score on a scaleStandard Deviation 0.51
Standard of Care Plus Education (SOC-ED)Change in Emotion-Focused Coping2.25 score on a scaleStandard Deviation 0.49
95% CI: [-0.13, 0.1]
Secondary

Change in Frailty

Frailty will be measured by performance on the Fried Frailty Index. This assessment includes measures on patient's weight, exhaustion level, physical activity, walking speed, and hand grip strength at baseline and again post-intervention at 12 weeks. Scores range from 0 to 5, with lower scores indicating less frailty. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: Assessment of frailty was limited due to the inability of participants to attend in person visits during COVID-19. Sixty-eight participants were missing the Fried Frailty Index measurement at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Frailty0.62 score on a scaleStandard Deviation 0.74
Standard of Care Plus Education (SOC-ED)Change in Frailty0.52 score on a scaleStandard Deviation 0.73
95% CI: [-0.22, 0.3]
Secondary

Change in Functional Capacity

Functional capacity will be measured by distance walked on a standard Six Minute Walk Test (6MWT) at baseline and again post-intervention at 12 weeks. Distance measured in feet. Greater distance represents better functional capacity. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: Assessment of functional capacity was limited due to the inability of participants to attend in person visits during COVID-19. Seventy-one participants were unable to complete the 6MWT at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Functional Capacity1451 feetStandard Deviation 332
Standard of Care Plus Education (SOC-ED)Change in Functional Capacity1472 feetStandard Deviation 262
95% CI: [-44, 85]
Secondary

Change in Physical Activity

Daily physical activity (average steps per day) will be assessed via a wrist-worn activity monitor (Actigraph GT9X Link) for 7 consecutive days at baseline and again post-intervention at 12 weeks. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: 5 participants had missing data for the baseline and/or post-intervention physical activity (steps) measurement.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Physical Activity8037 steps per dayStandard Deviation 3103
Standard of Care Plus Education (SOC-ED)Change in Physical Activity8612 steps per dayStandard Deviation 3161
95% CI: [-979, 346]
Secondary

Change in Problem-Focused Coping

Coping was assessed via the Brief COPE Inventory, which is composed of scales that measure problem-focused coping, emotion-focused coping, and avoidant coping responses at baseline and again post-intervention at 12 weeks. Items are scored on a 4-point Likert scale, with 1 indicating a coping mechanism that the participant has not been doing at all, to 4 indicating a coping mechanism in which the participant has been doing a lot. A higher average score within the problem-focused subscale indicates better coping strategies. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: Two participants were missing a Brief COPE score at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Problem-Focused Coping2.64 score on a scaleStandard Deviation 0.79
Standard of Care Plus Education (SOC-ED)Change in Problem-Focused Coping2.73 score on a scaleStandard Deviation 0.79
95% CI: [-0.2, 0.17]
Secondary

Change in Quality of Life

Quality of Life will be assessed via the Lung Transplant Quality of Life Survey, which is comprised of 10 scales that measure symptoms, health perceptions, functioning, and well being at baseline and again post-intervention at 12 weeks. The QOL overall score ranges from 1 to 5, with a higher score indicating worse health. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: Two participants were missing a QOL score at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Quality of Life1.78 score on a scaleStandard Deviation 0.49
Standard of Care Plus Education (SOC-ED)Change in Quality of Life1.78 score on a scaleStandard Deviation 0.56
95% CI: [-0.1, 0.11]
Secondary

Change in Self-Efficacy

Self-efficacy will be assessed via the General Self-Efficacy Scale, which is a 10-item scale that measures emotional distress at baseline and again post-intervention at 12 weeks. Scores range from 10-40 with a higher score indicating better self-efficacy. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: 5 participants were missing a GSE score at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Self-Efficacy33.3 score on a scaleStandard Deviation 5.1
Standard of Care Plus Education (SOC-ED)Change in Self-Efficacy33.1 score on a scaleStandard Deviation 4.7
95% CI: [-0.83, 1.6]
Secondary

Change in Sleep Quality

Sleep quality (average total minutes of sleep per night) will be assessed via the Pittsburgh Sleep Quality Index at baseline and again post-intervention at 12 weeks. The change value is calculated as T2 (12 weeks) - T1 (baseline).

Time frame: Baseline to 12 weeks

Population: 8 participants were missing a PSQI score at baseline and/or post-intervention.

ArmMeasureValue (MEAN)Dispersion
Coping Skills Training Combined With Exercise (CSTEX)Change in Sleep Quality421 minutes per nightStandard Deviation 92
Standard of Care Plus Education (SOC-ED)Change in Sleep Quality401 minutes per nightStandard Deviation 66
95% CI: [-5, 34]
Secondary

Chronic Lung Allograft Dysfunction (CLAD) Free Survival

Time frame: Up to 3 years post-treatment

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026